Changes in renal function after implantation of continuous-flow left ventricular assist devices

Area of Science:

• Cardiology
• Nephrology
• Medical Devices

Background:

• Renal dysfunction is common in patients awaiting left ventricular assist device (LVAD) implantation.
• The cause of renal dysfunction (primary kidney disease vs. poor perfusion) is often unclear.

Purpose of the Study:

• To evaluate renal outcomes following left ventricular assist device (LVAD) implantation.
• To identify predictors of improved renal function after LVAD.

Main Methods:

• Retrospective analysis of 83 patients receiving HeartMate II continuous-flow LVADs.
• Calculated glomerular filtration rate (GFR) assessed pre-operatively and at 1, 3, and 6 months post-implantation.
• Analysis of clinical variables to predict GFR improvement in patients with pre-LVAD GFR <60 ml/min/1.73 m(2).

Main Results:

• GFR significantly increased from 53.2 ± 21.4 ml/min/1.73 m(2) pre-LVAD to 87.4 ± 27.9 ml/min/1.73 m(2) at 1 month (p < 0.0001).
• Renal function remained significantly elevated at 3 and 6 months post-LVAD.
• Of patients with pre-LVAD GFR <60, 67% improved to >60 ml/min/1.73 m(2) at 1 month.
• Independent predictors for GFR improvement included pre-operative GFR improvement, atrial fibrillation, and intra-aortic balloon pump use.

Conclusions:

• Renal dysfunction in patients with end-stage heart failure is frequently reversible after LVAD implantation.
• The findings suggest poor renal perfusion is a primary driver of renal dysfunction in this population.
• LVAD therapy can restore renal function, highlighting its systemic benefits.